Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity

Yi-Cheng Chang^#^{1

2

3}, Meng-Lun Hsieh^#⁴, Hsiao-Lin Lee^#^{1

2}, Siow-Wey Hee¹, Chi-Fon Chang⁵, Hsin-Yung Yen⁶, Yi-An Chen⁶, Yet-Ran Chen⁷, Ya-Wen Chou⁷, Fu-An Li³, Yi-Yu Ke⁸, Shih-Yi Chen², Ming-Shiu Hung⁹, Alfur Fu-Hsin Hung¹⁰, Jing-Yong Huang^{1

2}, Chu-Hsuan Chiu², Shih-Yao Lin¹¹, Sheue-Fang Shih¹², Chih-Neng Hsu¹³, Juey-Jen Hwang^{1

13}, Teng-Kuang Yeh⁹, Ting-Jen Rachel Cheng⁵, Karen Chia-Wen Liao¹⁴, Daniel Laio², Shu-Wha Lin^{15

16}, Tzu-Yu Chen¹⁷, Chun-Mei Hu⁵, Ulla Vogel¹⁸, Daniel Saar^{19

20

21}, Birthe B Kragelund^{19

20

21}, Lun Kelvin Tsou²², Yu-Hua Tseng²³, Lee-Ming Chuang²⁴

Affiliations

¹ Department of Internal Medicine, National Taiwan University Hospital, Taipei, 100225, Taiwan.
² Graduate Institute of Medical Genomics and Proteomics, National Taiwan University, Taipei, 100225, Taiwan.
³ Institute of Biomedical Sciences, Academia Sinica, Taipei, 115201, Taiwan.
⁴ Department of Medicinal Chemistry, University of Florida, Gainesville, FL, 32610, USA.
⁵ Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan.
⁶ Institute of Biological Chemistry, Academia Sinica, Taipei, 115201, Taiwan.
⁷ Agricultural Biotechnology Research Center, Academia Sinica, Taipei, 115201, Taiwan.
⁸ Institute for Drug Evaluation Platform, Development Center for Biotechnology, Taipei, 11571, Taiwan.
⁹ Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Miaoli County, 35053, Taiwan.
¹⁰ Rakuten Medical, San Diego, CA, 92121, USA.
¹¹ AltruBio Taiwan R&D Center, Taipei, 114063, Taiwan.
¹² Taiwan Liposome Company, Taipei, 11560, Taiwan.
¹³ Department of Internal Medicine, National Taiwan University Hospital, Yunlin branch, Yunlin, 64041, Taiwan.
¹⁴ Biological Sciences Division, University of Chicago, Chicago, IL, 60637, USA.
¹⁵ Centers of Genomic and Precision Medicine, National Taiwan University, Taipei, 100225, Taiwan.
¹⁶ Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, 10048, Taiwan.
¹⁷ National Laboratory Animal Center, National Applied Research Laboratories, Taipei, 11571, Taiwan.
¹⁸ National Research Centre for the Working Environment, Lerso Parkallé 105, DK-2100, Copenhagen, Denmark.
¹⁹ REPIN, University of Copenhagen, Ole Maaloes Vej 5, DK-2200, Copenhagen N, Denmark.
²⁰ Structural Biology and NMR Laboratory, Department of Biology, University of Copenhagen, Ole Maaløes Vej 5, 2200, Copenhagen, Denmark.
²¹ The Linderstrøm-Lang Centre for Protein Science, University of Copenhagen, Ole Maaløes Vej 5, DK-2200, Copenhagen, Denmark.
²² Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Miaoli County, 35053, Taiwan. kelvintsou@nhri.edu.tw.
²³ Joslin Diabetes Center, Harvard Medical School, Boston, MA, 022515, USA. yu-hua.tseng@joslin.harvard.edu.
²⁴ Department of Internal Medicine, National Taiwan University Hospital, Taipei, 100225, Taiwan. leeming@ntu.edu.tw.

^# Contributed equally.

PMID: 40181187
PMCID: PMC12081718
DOI: 10.1038/s44321-025-00228-0

Published Erratum

Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity

Yi-Cheng Chang et al. EMBO Mol Med. 2025 May.

. 2025 May;17(5):1184.

doi: 10.1038/s44321-025-00228-0.

Authors

Affiliations

¹ Department of Internal Medicine, National Taiwan University Hospital, Taipei, 100225, Taiwan.
² Graduate Institute of Medical Genomics and Proteomics, National Taiwan University, Taipei, 100225, Taiwan.
³ Institute of Biomedical Sciences, Academia Sinica, Taipei, 115201, Taiwan.
⁴ Department of Medicinal Chemistry, University of Florida, Gainesville, FL, 32610, USA.
⁵ Genomics Research Center, Academia Sinica, Taipei, 115201, Taiwan.
⁶ Institute of Biological Chemistry, Academia Sinica, Taipei, 115201, Taiwan.
⁷ Agricultural Biotechnology Research Center, Academia Sinica, Taipei, 115201, Taiwan.
⁸ Institute for Drug Evaluation Platform, Development Center for Biotechnology, Taipei, 11571, Taiwan.
⁹ Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Miaoli County, 35053, Taiwan.
¹⁰ Rakuten Medical, San Diego, CA, 92121, USA.
¹¹ AltruBio Taiwan R&D Center, Taipei, 114063, Taiwan.
¹² Taiwan Liposome Company, Taipei, 11560, Taiwan.
¹³ Department of Internal Medicine, National Taiwan University Hospital, Yunlin branch, Yunlin, 64041, Taiwan.
¹⁴ Biological Sciences Division, University of Chicago, Chicago, IL, 60637, USA.
¹⁵ Centers of Genomic and Precision Medicine, National Taiwan University, Taipei, 100225, Taiwan.
¹⁶ Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, 10048, Taiwan.
¹⁷ National Laboratory Animal Center, National Applied Research Laboratories, Taipei, 11571, Taiwan.
¹⁸ National Research Centre for the Working Environment, Lerso Parkallé 105, DK-2100, Copenhagen, Denmark.
¹⁹ REPIN, University of Copenhagen, Ole Maaloes Vej 5, DK-2200, Copenhagen N, Denmark.
²⁰ Structural Biology and NMR Laboratory, Department of Biology, University of Copenhagen, Ole Maaløes Vej 5, 2200, Copenhagen, Denmark.
²¹ The Linderstrøm-Lang Centre for Protein Science, University of Copenhagen, Ole Maaløes Vej 5, DK-2200, Copenhagen, Denmark.
²² Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Miaoli County, 35053, Taiwan. kelvintsou@nhri.edu.tw.
²³ Joslin Diabetes Center, Harvard Medical School, Boston, MA, 022515, USA. yu-hua.tseng@joslin.harvard.edu.
²⁴ Department of Internal Medicine, National Taiwan University Hospital, Taipei, 100225, Taiwan. leeming@ntu.edu.tw.

^# Contributed equally.

PMID: 40181187
PMCID: PMC12081718
DOI: 10.1038/s44321-025-00228-0

No abstract available

PubMed Disclaimer

Erratum for

Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.
Chang YC, Hsieh ML, Lee HL, Hee SW, Chang CF, Yen HY, Chen YA, Chen YR, Chou YW, Li FA, Ke YY, Chen SY, Hung MS, Hung AF, Huang JY, Chiu CH, Lin SY, Shih SF, Hsu CN, Hwang JJ, Yeh TK, Cheng TR, Liao KC, Laio D, Lin SW, Chen TY, Hu CM, Vogel U, Saar D, Kragelund BB, Tsou LK, Tseng YH, Chuang LM. Chang YC, et al. EMBO Mol Med. 2025 May;17(5):938-966. doi: 10.1038/s44321-025-00216-4. Epub 2025 Mar 21. EMBO Mol Med. 2025. PMID: 40119175 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity

Affiliations

Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources